- Is Upstage Lung Cancer a tax-exempt 501(c)(3)?
- Yes. Upstage Lung Cancer is recognised by the IRS as a 501(c)(3) organisation (EIN 26-3303949). The IRS recognised Upstage Lung Cancer as tax-exempt in June 2009.
- What is Upstage Lung Cancer's EIN?
- Upstage Lung Cancer's Employer Identification Number (EIN) is 26-3303949. The EIN was assigned by the IRS in June 2009. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.
- What does Upstage Lung Cancer do?
- Upstage Lung Cancer is registered with the IRS as a medical research nonprofit organisation. A detailed mission statement is not available on its most recent Form 990 filing.
- Where is Upstage Lung Cancer located?
- Upstage Lung Cancer is located at PO Box 844, Brookline, MA, 02446.
- When was Upstage Lung Cancer founded or recognised by the IRS?
- Upstage Lung Cancer was recognised by the IRS as a tax-exempt organisation in June 2009. The IRS ruling date is the earliest authoritative date available for most US nonprofits.
- What is Upstage Lung Cancer's annual revenue?
- On its most recent Form 990 (fiscal year 2024), Upstage Lung Cancer reported $151K in total revenue and $102K in total expenses.
- Has Upstage Lung Cancer been auto-revoked by the IRS?
- No. Upstage Lung Cancer (EIN 26-3303949) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.
- Is Upstage Lung Cancer listed in IRS Publication 78?
- Yes. Upstage Lung Cancer is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.
